Morning Commentary: Medicines convertibles higher in active trade; Depomed deflects Horizon offer

By Rebecca Melvin

New York, July 7 – The Medicines Co.’s convertibles remained in focus early Tuesday, trading firm to higher in active trade in a continuation of action seen on Monday.

The Medicines newer 2.5% convertibles due 2022 looked to be up more than 3 points to 118, according to Trace data.

The older Medicines 1.375% convertibles due 2017 moved up a couple of points to 128.

Shares of the Parsippany, N.J.-based health care company were trending higher in active trade and last seen up fractionally at close to $33.00 per share.

Medicines had been trading on Monday as well on a good stock move. The bonds had traded in slightly on Monday and were firm to better on Tuesday.

The big mover in the health care space was Depomed Inc. on M&A news. The company rejected a hostile takeover bid from Horizon Pharma plc in an offer that represented a 42% premium over Depomed’s closing share price on Monday.

Depomed shares were up 36% early Tuesday. The bonds were seen at 155.125 bid, 156.125 offered last with the shares at about $27.00, a trader said.

Horizon is also a convertibles issuer. It priced $400 million of 2.5% convertibles in early March. Horizon shares were down about 5%, but the convertibles were not heard in trade.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.